We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+17.84%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$6.62B
AUM Growth
+$1.04B
Cap. Flow
+$354M
Cap. Flow %
5.34%
Top 10 Hldgs %
56.45%
Holding
75
New
10
Increased
28
Reduced
21
Closed
9

Top Buys

Rank Stock Value
1
FLR icon
Fluor
FLR
+$160M
2
VTRS icon
Viatris
VTRS
+$101M
3
FTAI icon
FTAI Aviation
FTAI
+$83.8M
4
VST icon
Vistra
VST
+$70.9M
5
PCG icon
PG&E
PCG
+$58.6M

Sector Composition

Rank Sector Weight
1 Healthcare 32.2%
2 Utilities 29.09%
3 Industrials 10.97%
4 Energy 7.79%
5 Financials 5.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADPT icon
26
Adaptive Biotechnologies
ADPT
$4.04B
$72.9M 1.1%
6,256,847
-6,861,004
-52% -$62.3M
INDV icon
27
Indivior Pharmaceuticals
INDV
$4.54B
$68.5M 1.03%
4,647,179
+1,117,140
+32% +$13M
OPK icon
28
Opko Health
OPK
$1.04B
$63.1M 0.95%
47,791,243
-915,397
-2% -$1.25M
ADEA icon
29
Adeia
ADEA
$3.06B
$60.6M 0.92%
4,284,205
-50,926
-1% -$659K
ZYME icon
30
Zymeworks
ZYME
$1.73B
$59.1M 0.89%
4,710,551
+372,107
+9% +$4.43M
LBTYA icon
31
Liberty Global Class A
LBTYA
$3.48B
$57M 0.86%
5,692,225
-310,426
-5% -$3.12M
DK icon
32
Delek US
DK
$3.92B
$56.9M 0.86%
2,687,449
HRTX icon
33
Heron Therapeutics
HRTX
$61.5M
$55.3M 0.84%
26,713,503
COOP
34
DELISTED
Mr. Cooper
COOP
$50.4M 0.76%
337,924
-583,613
-63% -$74.8M
PCG icon
35
PG&E
PCG
$38.1B
$50.2M 0.76%
+3,600,000
New +$58.6M
TRVI icon
36
Trevi Therapeutics
TRVI
$2.54B
$46.7M 0.71%
8,531,860
+3,993,325
+88% +$24.8M
CNNE icon
37
Cannae Holdings
CNNE
$644M
$43.9M 0.66%
2,105,864
+615,616
+41% +$11.4M
OFIX icon
38
Orthofix Medical
OFIX
$420M
$41.5M 0.63%
3,721,715
+26,769
+0.7% +$332K
MREO
39
Mereo BioPharma
MREO
$48.8M
$41.5M 0.63%
15,307,347
PRLB icon
40
Protolabs
PRLB
$2.16B
$41.4M 0.63%
1,034,171
+918,219
+792% +$34.2M
ECVT icon
41
Ecovyst
ECVT
$1.11B
$38.7M 0.59%
+4,707,347
New +$33M
LBTYK icon
42
Liberty Global Class C
LBTYK
$3.4B
$33.9M 0.51%
3,289,789
-3,729
-0.1% -$38.6K
XPER icon
43
Xperi
XPER
$323M
$32.8M 0.5%
4,143,744
GEO icon
44
The GEO Group
GEO
$4.18B
$29.9M 0.45%
1,247,393
+571,502
+85% +$15.6M
MATV icon
45
Mativ Holdings
MATV
$706M
$27.2M 0.41%
3,982,442
-17,558
-0.4% -$101K
CMPR icon
46
Cimpress
CMPR
$2.32B
$26.4M 0.4%
+561,429
New +$24.5M
IAS
47
DELISTED
Integral Ad Science
IAS
$24.7M 0.37%
2,971,951
-194,998
-6% -$1.49M
MGTX icon
48
MeiraGTx Holdings
MGTX
$1.21B
$24.3M 0.37%
3,726,451
+1,950,130
+110% +$11.5M
SPRY icon
49
ARS Pharmaceuticals
SPRY
$591M
$22.6M 0.34%
1,294,878
+265,777
+26% +$3.83M
SUPN icon
50
Supernus Pharmaceuticals
SUPN
$2.73B
$21.9M 0.33%
+695,039
New +$22.3M

Similar funds

Rubric Capital Management (New York)'s Q2 2025 Portfolio in Review

As of Q2 2025, Rubric Capital Management (New York) held 75 positions worth $6.62B, up 19% from $5.58B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Rubric Capital Management (New York) deployed $354M of net new capital in Q2 2025, opening 10 new positions and adding to 28 existing holdings. Its largest new stake was Fluor: 4,000,000 shares worth $205M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 37% a quarter earlier, followed by Utilities and Industrials.

On the sell side, the largest reduction was Talen Energy Corp, an estimated $384M trimmed.

  • Rubric Capital Management (New York)'s largest Q2 2025 buy was Fluor: 4,000,000 shares worth $205M.
  • Rubric Capital Management (New York) added most to FTAI Aviation in Q2 2025, an estimated $83.8M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2025 reduction was Talen Energy Corp, cutting an estimated $384M.
  • Rubric Capital Management (New York) fully exited Flagstar Bank National Association in Q2 2025, selling an estimated $74.7M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 56% of its $6.62B portfolio in Q2 2025.
  • Rubric Capital Management (New York) opened 10 new positions and closed 9 in Q2 2025.
  • Rubric Capital Management (New York)'s portfolio value rose 19% quarter-over-quarter to $6.62B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2025, filed 14 Aug 2025.